Amy Sing Net Worth & Insider Trades

Amy Sing - Sr. Director Medical Affairs, Seattle Genetics Inc /wa

As of August 18, 2003

What is Amy Sing's Net Worth?

The current estimated net worth of Seattle Genetics Inc /wa's Sr. Director Medical Affairs, Amy Sing, is estimated to be about $15.51M . Amy Sing owns about 52,107 units of Seattle Genetics Inc /wa common stock. Recently at Seattle Genetics Inc /wa, Amy Sing has sold an estimated value of $125.34K worth.

What is Amy Sing's Past Insider Trading?

Amy Sing's largest sale order was 20,000 units , worth over $101.84K on August 18, 2003. In total, Amy Sing has made about 2 transactions recently at Seattle Genetics Inc /wa. Amy Sing usually trades in August, with the busiest year in 2003.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Amy Sing's' Mailing Address?

  • Mailing address is C/o Saettle Genetics Inc 21823 30th Drive Se Bothell WA 98021 WA

Seattle Genetics Inc /wa Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Clay B. Siegall, Ph.D. 2020 $1,043,651 - $9,295,156 $17,127 $17,127 $17,127 $16,493,557
Clay B. Siegall, Ph.D. 2019 $963,369 - $8,137,179 $15,230 $15,230 $15,230 $14,521,495
Clay B. Siegall, Ph.D. 2018 $918,554 $2,000 $8,217,394 $19,302 $19,302 $19,302 $18,107,037
Todd E. Simpson 2020 $601,600 $1,500 $2,132,760 $17,127 $17,127 $17,127 $4,601,531
Todd E. Simpson 2019 $572,342 - $1,824,697 $15,230 $15,230 $15,230 $4,490,092
Todd E. Simpson 2018 $519,458 $13,300 $1,847,912 $12,855 $12,855 $12,855 $4,432,362
Roger D. Dansey, M.D. 2020 $711,467 - $3,258,442 $181,812 $181,812 $181,812 $7,061,537
Roger D. Dansey, M.D. 2019 $670,900 $150,000 $2,831,698 $294,460 $294,460 $294,460 $6,718,824
Roger D. Dansey, M.D. 2018 $399,479 $300,000 $6,804,499 $176,312 $176,312 $176,312 $9,927,020
Chip R. Romp 2020 $488,708 $1,500 $2,477,660 $1,452 $1,452 $1,452 $4,577,582
Chip R. Romp 2019 $437,233 $125,000 $2,062,862 $1,999 $1,999 $1,999 $3,382,642
Chip R. Romp 2018 $409,646 - $1,101,443 $815 $815 $815 $2,239,475
Jean I. Liu 2020 $546,125 - $1,777,282 $17,127 $17,127 $17,127 $3,913,724
Jean I. Liu 2019 $520,325 $500 $1,578,609 $15,230 $15,230 $15,230 $3,966,121
Jean I. Liu 2018 $485,017 $13,300 $1,536,026 $12,855 $12,855 $12,855 $3,761,188
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312521102519/d84416ddef14a.htm

What are Seattle Genetics Inc /wa's Past Insider Trades?

Seattle Genetics Inc /wa's most recent insider trade came on November 13, 2023 by David R Epstein who sold 10,620 units worth $2.26M . In the last 20 years, insiders at Seattle Genetics Inc /wa have sold an estimated value of $1.21B and bought an estimated value of $1.56B worth of shares. Insider trading is most common in May, with the busiest year in 2020. The most active traders at the company are Felix Baker, Director,  Julian Baker, Director,  and Clay B Siegall, President & CEO .

Seagen Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...